» Articles » PMID: 22464815

Mesenchymal Stem Cells Promote Neutrophil Activation by Inducing IL-17 Production in CD4+ CD45RO+ T Cells

Overview
Journal Immunobiology
Publisher Elsevier
Date 2012 Apr 3
PMID 22464815
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) are multi-potent with numerous mesenchymal-lineage differentiation potential and immunomodulatory capabilities. However, the immunoregulatory properties of MSCs are not clearly defined. The objective of the present study was to elucidate the role(s) of MSCs in IL-17 production and the subsequent effect(s) on neutrophil activation. We have demonstrated that human bone marrow-derived MSCs (BM-MSCs) instruct anti-CD3/anti-CD28 antibody-activated CD4(+) CD45RO(+) memory T cells, but not other CD4(+) subsets or CD8(+) T cells, to produce IL-17 after cell-cell contact. After the addition of IL-17, neutrophil phagocytic activity was increased. This is the first report on the ability of BM-MSCs to induce IL-17 production in memory CD4(+) T cells that, in turn, promotes enhanced phagocytic activity of neutrophils. These results suggest that MSCs regulate the functional activation of neutrophils via their role in modulating IL-17 from CD4(+) CD45RO(+) memory T cells.

Citing Articles

Mesenchymal stem cells modulate IL-17 and IL-9 production induced by Th17-inducing cytokine conditions in autoimmune arthritis: an explorative analysis.

Riekert M, Almanzar G, Schmalzing M, Schutze N, Jakob F, Prelog M Adv Rheumatol. 2023; 63(1):37.

PMID: 37525265 DOI: 10.1186/s42358-023-00317-z.


Subcutaneous Injection of Allogeneic Adipose-Derived Mesenchymal Stromal Cells in Psoriasis Plaques: Clinical Trial Phase I.

Bajouri A, Dayani D, Taj Sharghi A, Karimi S, Niknezhadi M, Moeinabadi Bidgoli K Cell J. 2023; 25(6):363-371.

PMID: 37434453 PMC: 10331441. DOI: 10.22074/cellj.2023.1973793.1167.


Mesenchymal stem cell therapy for ischemic stroke: Novel insight into the crosstalk with immune cells.

Tan N, Xin W, Huang M, Mao Y Front Neurol. 2022; 13:1048113.

PMID: 36425795 PMC: 9679024. DOI: 10.3389/fneur.2022.1048113.


Immune Activated Cellular Therapy for Drug Resistant Infections: Rationale, Mechanisms, and Implications for Veterinary Medicine.

Pezzanite L, Chow L, Strumpf A, Johnson V, Dow S Vet Sci. 2022; 9(11).

PMID: 36356087 PMC: 9695672. DOI: 10.3390/vetsci9110610.


Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke.

Zhou L, Zhu H, Bai X, Huang J, Chen Y, Wen J Stem Cell Res Ther. 2022; 13(1):195.

PMID: 35551643 PMC: 9096773. DOI: 10.1186/s13287-022-02876-2.